Allmed Medical Products Co., Ltd.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100003JM5
CNY
14.17
-0.29 (-2.01%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
896.09
920.27
917.68
758.66
876.22
868.42
835.24
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
896.09
920.27
917.68
758.66
876.22
868.42
835.24
Raw Material Cost
603.32
639.34
667.98
542.72
620.80
654.70
612.33
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
4.57
2.16
3.03
4.86
4.40
6.33
6.69
Selling and Distribution Expenses
108.93
88.81
68.68
83.95
80.27
89.82
81.25
Other Expenses
2.37
1.56
2.37
2.27
4.29
1.15
1.20
Total Expenditure (Excl Depreciation)
740.53
745.91
763.42
654.25
748.38
762.36
712.29
Operating Profit (PBDIT) excl Other Income
155.6
174.4
154.3
104.39999999999999
127.8
106.1
122.89999999999999
Other Income
-2.18
15.04
20.10
16.39
44.68
6.96
16.01
Operating Profit (PBDIT)
144.64
184.91
210.12
175.24
197.06
163.49
192.17
Interest
4.57
2.16
3.03
4.86
4.40
6.33
6.69
Exceptional Items
-8.01
-0.28
-0.10
4.61
-15.04
-0.15
-1.76
Gross Profit (PBDT)
292.78
280.93
249.70
215.94
255.42
213.72
222.91
Depreciation
0.00
0.00
61.82
61.82
58.09
58.09
58.06
Profit Before Tax
132.05
182.47
145.18
113.18
119.53
98.92
125.67
Tax
18.36
25.36
22.71
24.97
20.77
16.92
27.37
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
108.95
148.97
113.33
86.50
103.51
78.17
93.12
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
108.95
148.97
113.33
86.50
103.51
78.17
93.12
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
4.34
2.54
3.39
0.15
-0.40
0.23
0.04
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
113.29
151.51
116.72
86.65
103.11
78.40
93.16
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
3,697.52
3,730.97
3,582.17
3,514.54
3,436.53
3,335.46
3,254.21
Earnings per share (EPS)
0.18
0.24
0.18
0.14
0.17
0.13
0.15
Diluted Earnings per share
0.18
0.24
0.18
0.14
0.17
0.13
0.15
Operating Profit Margin (Excl OI)
16.38%
18.46%
13.97%
12.79%
10.76%
11.34%
14.14%
Gross Profit Margin
14.74%
19.83%
22.56%
23.07%
20.27%
18.08%
22.0%
PAT Margin
12.16%
16.19%
12.35%
11.4%
11.81%
9.0%
11.15%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Mar 2026 is -2.63% vs 0.28% in Sep 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Mar 2026 is -25.21% vs 29.82% in Sep 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2026 is -13.60% vs -10.58% in Sep 2025

stock-summary

Interest

QoQ Growth in quarter ended Mar 2026 is 109.09% vs -26.67% in Sep 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2026 has fallen from Sep 2025

Compare Quarterly Results Of Allmed Medical Products Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
896.09
0
896.09
Other Operating Income
0.00
0.00
0.00
Total Operating income
896.09
0
896.09
Raw Material Cost
603.32
0
603.32
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
4.57
0
4.57
Selling and Distribution Expenses
108.93
0
108.93
Other Expenses
2.37
0.00
2.37
Total Expenditure (Excl Depreciation)
740.53
0
740.53
Operating Profit (PBDIT) excl Other Income
155.56
0.00
155.56
Other Income
-2.18
0
-2.18
Operating Profit (PBDIT)
144.64
0
144.64
Interest
4.57
0
4.57
Exceptional Items
-8.01
0
-8.01
Gross Profit (PBDT)
292.78
0
292.78
Depreciation
0.00
0
0.00
Profit Before Tax
132.05
0
132.05
Tax
18.36
0
18.36
Provisions and contingencies
0
0
0.00
Profit After Tax
108.95
0
108.95
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
108.95
0
108.95
Share in Profit of Associates
0
0
0.00
Minority Interest
4.34
0
4.34
Other related items
0.00
0.00
0.00
Consolidated Net Profit
113.29
0
113.29
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
3,697.52
0
3,697.52
Earnings per share (EPS)
0.18
0
0.18
Diluted Earnings per share
0.18
0
0.18
Operating Profit Margin (Excl OI)
16.38%
0%
0.00
16.38%
Gross Profit Margin
14.74%
0%
0.00
14.74%
PAT Margin
12.16%
0%
0.00
12.16%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 89.61 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -2.63% vs 0.28% in Sep 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 18.11% vs 2.28% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 11.33 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -25.21% vs 29.82% in Sep 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 30.68% vs -7.86% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 14.68 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -13.60% vs -10.58% in Sep 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -7.61% vs -4.33% in Mar 2025

Quarterly - Interest
Interest 0.46 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 109.09% vs -26.67% in Sep 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -6.12% vs -39.51% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 16.38%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has fallen from Sep 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025